The role of initial trauma in the host's response to injury and hemorrhage: Insights from a correlation of mathematical simulations and hepatic transcriptomic analysis

Shock

Volumn 26, Issue 6, 2006, Pages 592-600

  Lagoa, Claudio E ^a   Bartels, John ^b   Baratt, Arie ^b   Tseng, George ^c   Clermont, Gilles ^c,d   Fink, Mitchell P ^d   Billiar, Timothy R ^a   Vodovotz, Yoram ^a,c  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b IMMUNETRICS INC   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Genomics; Hemorrhagic shock; Mathematical modeling; Microarray; Trauma

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLEEDING; CALIBRATION; CANNULATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DATA ANALYSIS; DEATH; DEVICE; DNA MICROARRAY; ENDOTOXEMIA; GENE EXPRESSION; GENE PROBE; HEMORRHAGIC SHOCK; INFLAMMATION; INJURY; LIVER; MATHEMATICAL MODEL; MICROARRAY ANALYSIS; MOUSE; MULTIPLE ORGAN FAILURE; NONHUMAN; PATHOPHYSIOLOGY; PHENOTYPE; PREDICTION; RESUSCITATION; SIMULATION; SURGICAL INJURY; SYSTEMS BIOLOGY; TISSUE INJURY; TRANSCRIPTOMICS; VALIDATION STUDY;

ANIMALS; COMPUTER SIMULATION; DISEASE MODELS, ANIMAL; GENOMICS; INFLAMMATION; INTERLEUKIN-10; INTERLEUKIN-6; LIVER; MICE; MICE, INBRED C57BL; MODELS, THEORETICAL; NITRIC OXIDE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SHOCK, HEMORRHAGIC; TRANSCRIPTION, GENETIC; WOUNDS AND INJURIES;

EID: 33751222859     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.shk.0000232272.03602.0a     Document Type: Article

References (61)

1. Meyer AA: Death and disability from injury: a global challenge. J Trauma 44:1-12, 1998.
2. Giannoudis PV: Current concepts of the inflammatory response after major trauma: an update. Injury 34:397-404, 2003.
3. Pastores SM, Thakkar A, Gennis P, Katz DP, Kvetan V: Posttraumatic multiple-organ dysfunction syndrome: role of mediators in systemic inflammation and subsequent organ failure. Acad Emerg Med 3:611-622, 1996.
4. Saadia R, Lipman J: Multiple organ failure after trauma. BMJ 313:573-574, 1996.
5. Fink MP: Gastrointestinal mucosal injury in experimental models of shock, trauma, and sepsis. Crit Care Med 19:627-641, 1991.
6. Harbrecht BG, Doyle HR, Clancy KD, Townsend RN, Billiar TR, Peitzman AB: The impact of liver dysfunction on outcome in patients with multiple injuries. Am Surg 67:122-126, 2001.
7. Lagoa CE, de Figueiredo LF, Cruz RJ Jr, Silva E, e Silva R: Effects of volume resuscitation on splanchnic perfusion in canine model of severe sepsis induced by live Escherichia coli infusion. Crit Care 8:R221-R228, 2004.
8. Moore FA: The role of the gastrointestinal tract in postinjury multiple organ failure. Am J Surg 178:449-453, 1999.
9. Tamion F, Richard V, Lyoumi S, Daveau M, Bonmarchand G, Leroy J, Thuillez C, Lebreton JP: Gut ischemia and mesenteric synthesis of inflammatory cytokines after hemorrhagic or endotoxic shock. Am J Physiol 273:G314-G321, 1997.
10. Rotstein OD: Modeling the two-hit hypothesis for evaluating strategies to prevent organ injury after shock/resuscitation. J Trauma 54:S203-S206, 2003.
11. Neugebauer EA, Willy C, Sauerland S: Complexity and non-linearity in shock research: reductionism or synthesis? Shock 16:252-258, 2001.
12. Buchman TG: Nonlinear dynamics, complex systems, and the pathobiology of critical illness. Curr Opin Crit Care 10:378-382, 2004.
13. Seely AJ, Christou NV: Multiple organ dysfunction syndrome: exploring the paradigm of complex nonlinear systems. Crit Care Med 28:2193-2200, 2000.
14. Freeman BD, Natanson C: Anti-inflammatory therapies in sepsis and septic shock. Expert Opin Investig Drugs 9:1651-1663, 2000.
15. Opal SM: Clinical trial design and outcomes in patients with severe sepsis. Shock 20:295-302, 2003.
16. Remick DG: Cytokine therapeutics for the treatment of sepsis: why has nothing worked? Curr Pharm Des 9:75-82, 2003.
17. Nathan C: Points of control in inflammation. Nature 420:846-852, 2002.
18. Zeni F, Freeman B, Natanson C: Anti-inflammatory therapies to treat sepsis and septic shock: a reassessment. Crit Care Med 25:1095-1100, 1997.
19. Ge H, Walhout AJ, Vidal M: Integrating 'omic' information: a bridge between genomics and systems biology. Trends Genet 19:551-560, 2003.
20. Kitano H: Systems biology: a brief overview. Science 295:1662-1664, 2002.
21. Kitano H: Computational systems biology. Nature 420:206-210, 2002.
22. Weeraratna AT, Nagel JE, Mello-Coelho V, Taub DD: Gene expression profiling: from microarrays to medicine. J Clin Immunol 24:213-224, 2004.
23. Vodovotz Y, Clermont G, Chow C, An G: Mathematical models of the acute inflammatory response. Curr Opin Crit Care 10:383-390, 2004.
24. Chow CC, Clermont G, Kumar R, Lagoa C, Tawadrous Z, Gallo D, Betten B, Bartels J, Constantine G, Fink MP, et al: The acute inflammatory response in diverse shock states. Shock 24:74-84, 2005.
25. Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie T, Eisen MB, van de RM, Jeffrey SS, et al: Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A 98:10869-10874, 2001.
26. Sun N, Zhao H: Genomic approaches in dissecting complex biological pathways. Pharmacogenomics 5:163-179, 2004.
27. Cobb JP, Brownstein BH, Watson MA, Shannon WD, Laramie JM, Qiu Y, Stormo GD, Morrissey JJ, Buchman TG, Karl IE, et al: Injury in the era of genomics. Shock 15:165-170, 2001.
28. Cobb JP, Laramie JM, Stormo GD, Morrissey JJ, Shannon WD, Qiu Y, Karl IE, Buchman TG, Hotchkiss RS: Sepsis gene expression profiling: murine splenic compared with hepatic responses determined by using complementary DNA microarrays. Crit Care Med 30:2711-2721, 2002.
29. Lagoa CE, Vodovotz Y, Stolz DB, Lhuillier F, McCloskey C, Gallo D, Yang R, Ustinova E, Fink MP, Billiar TR, et al: The role of hepatic type 1 plasminogen activator inhibitor (PAI-1) during murine hemorrhagic shock. Hepatology 42:390-399, 2005.
30. Vodovotz Y: Modified microassay for serum nitrite and nitrate. Biotechniques 20:390-392, 394, 1996.
31. Brownstein BH, Logvinenko T, Lederer JA, Cobb JP, Hubbard WJ, Chaudry IH, Remick DG, Baker HV, Xiao W, Mannick JA: Commonality and differences in leukocyte gene expression patterns among three models of inflammation and injury. Physiol Genomics 24:298-309, 2006.
32. Calvano SE, Xiao W, Richards DR, Felciano RM, Baker HV, Cho RJ, Chen RO, Brownstein BH, Cobb JP, Tschoeke SK, et al: A network-based analysis of systemic inflammation in humans. Nature 437:1032-1037, 2005.
33. Vodovotz Y, Chow CC, Bartels J, Lagoa CE, Prince JM, Levy RM, Kumar R, Day J, Rubin J, Constantine G, et al: In silico models of acute inflammation in animals. Shock 2006. In press.
34. Clermont G, Bartels J, Kumar R, Constantine G, Vodovotz Y, Chow C: In silico design of clinical trials: a method coming of age. Crit Care Med 32:2061-2070, 2004.
35. Kumar R, Clermont G, Vodovotz Y, Chow CC: The dynamics of acute inflammation. J Theor Biol 230:145-155, 2004.
36. Matzinger P: The danger model: a renewed sense of self. Science 296:301-305, 2002.
37. Dhainaut JF, Marin N, Mignon A, Vinsonneau C: Hepatic response to sepsis: interaction between coagulation and inflammatory processes. Crit Care Med 29:S42-S47, 2001.
38. Harbrecht BG, Di Silvio M, Demetris AJ, Simmons RL, Billiar TR: Tumor necrosis factor-alpha regulates in vivo nitric oxide synthesis and induces liver injury during endotoxemia. Hepatology 20:1055-1060, 1994.
39. Harbrecht BG, Wu B, Watkins SC, Marshall HP Jr, Peitzman AB, Billiar TR: Inhibition of nitric oxide synthase during hemorrhagic shock increases hepatic injury. Shock 4:332-337, 1995.
40. Hierholzer C, Harbrecht B, Menezes JM, Kane J, MacMicking J, Nathan CF, Peitzman AB, Billiar TR, Tweardy DJ: Essential role of induced nitric oxide in the initiation of the inflammatory response after hemorrhagic shock. J Exp Med 187:917-928, 1998.
41. Zamora R, Vodovotz Y, Aulak KS, Kim PK, Kane JM III, Alarcon L, Stuehr DJ, Billiar TR: A DNA microarray study of nitric oxide-induced genes in mouse hepatocytes: implications for hepatic heme oxygenase-1 expression in ischemia/reperfusion. Nitric Oxide 7:165-186, 2002.
42. Cobb JP, Buchman TG: microArRAY of hope. Shock 16:264-265, 2001.
43. Chinnaiyan AM, Huber-Lang M, Kumar-Sinha C, Barrette TR, Shankar-Sinha S, Sarma VJ, Padgaonkar VA, Ward PA: Molecular signatures of sepsis: multiorgan gene expression profiles of systemic inflammation. Am J Pathol 159:1199-1209, 2001.
44. Huang Q, Liu D, Majewski P, Schulte LC, Korn JM, Young RA, Lander ES, Hacohen N: The plasticity of dendritic cell responses to pathogens and their components. Science 294:870-875, 2001.
45. Tsan MF, Gao B: Endogenous ligands of toll-like receptors. J Leukoc Biol 76:514-519, 2004.
46. Chong AJ, Shimamoto A, Hampton CR, Takayama H, Spring DJ, Rothnie CL, Yada M, Pohlman TH, Verrier ED: Toll-like receptor 4 mediates ischemia/reperfusion injury of the heart. J Thorac Cardiovasc Surg 128:170-179, 2004.
47. Tsung A, Hoffman RA, Izuishi K, Critchlow ND, Nakao A, Chan MH, Lotze MT, Geller DA, Billiar TR: Hepatic ischemia/reperfusion injury involves functional TLR4 signaling in nonparenchymal cells. J Immunol 175:7661-7668, 2005.
48. Tsung A, Sahai R, Tanaka H, Nakao A, Fink MP, Lotze MT, Yang H, Li J, Tracey KJ, Geller DA: The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion. J Exp Med 201:1135-1143, 2005.
49. Kendziorski C, Irizarry RA, Chen KS, Haag JD, Gould MN: On the utility of pooling biological samples in microarray experiments. Proc Natl Acad Sci U S A 102:4252-4257, 2005.
50. Shih JH, Michalowska AM, Dobbin K, Ye Y, Qiu TH, Green JE: Effects of pooling mRNA in microarray class comparisons. Bioinformatics 20:3318-3325, 2004.
51. Bammler T, Beyer RP, Bhattacharya S, Boorman GA, Boyles A, Bradford BU, Bumgarner RE, Bushel PR, Chaturvedi K, Choi D, et al: Standardizing global gene expression analysis between laboratories and across platforms. Nat Methods 2:351-356, 2005.
52. Cobb JP, Mindrinos MN, Miller-Graziano C, Calvano SE, Baker HV, Xiao W, Laudanski K, Brownstein BH, Elson CM, Hayden DL, et al: Application of genome-wide expression analysis to human health and disease. Proc Natl Acad Sci U S A 102:4801-4806, 2005.
53. Hollingshead D, Lewis DA, Mirnics K: Platform influence on DNA microarray data in postmortem brain research. Neurobiol Dis 18:649-655, 2005.
54. Irizarry RA, Warren D, Spencer F, Kim IF, Biswal S, Frank BC, Gabrielson E, Garcia JG, Geoghegan J, Germino G, et al: Multiple-laboratory comparison of microarray platforms. Nat Methods 2:345-350, 2005.
55. Sherlock G: Analysis of large-scale gene expression data. Brief Bioinform 2:350-362, 2001.
56. Hatfield GW, Hung SP, Baldi P: Differential analysis of DNA microarray gene expression data. Mol Microbiol 47:871-877, 2003.
57. McShane LM, Shih JH, Michalowska AM: Statistical issues in the design and analysis of gene expression microarray studies of animal models. J Mammary Gland Biol Neoplasia 8:359-374, 2003.
58. Krajewski P, Bocianowski J: Statistical methods for microarray assays. J Appl Genet 43:269-278, 2002.
59. Prince JM, Ryan ML, Bartels J, Baratt A, Kanne JM III, Lagoa C, Rubin J, Day J, Wei J, Fink MP, et al: In silico and in vivo approach to elucidate the inflammatory complexity of CD14-deficient mice. Mol Med 2006. In press.
60. Buchman TG: The community of the self. Nature 420:246-251, 2002.
61. Cross AS, Opal SM: A new paradigm for the treatment of sepsis: is it time to consider combination therapy? Ann Intern Med 138:502-505, 2003.